Key facts
- TimeTeller's saliva test analyzes circadian rhythms.
- The company's long-term goal is to time cancer treatments for better tolerance and effectiveness.
- TimeTeller has partnered with German health insurer Techniker Krankenkasse.
TimeTeller aims to time cancer treatments to patients' internal clocks
IN SHORT
German startup TimeTeller has developed a saliva test to analyze individuals' circadian rhythms, aiming to personalize cancer treatments and reduce side effects. CEO Angela Relógio cautioned that the direct-to-consumer kit does not yet provide personalized medicine timing, which requires clinical studies.
Key Numbers
10TimeTeller's team size
12 millionTechniker Krankenkasse members
Who's Involved
TimeTeller
German startup developing a saliva test for circadian rhythms
Angela Relógio
CEO of TimeTeller and physicist-engineer
Benjamin Dose
cofounder of TimeTeller and biochemist
Techniker Krankenkasse
German health insurance provider
↳ Why This Matters
TimeTeller's approach could lead to more effective and less burdensome cancer treatments by aligning them with a patient's internal biological clock, potentially improving patient outcomes and reducing healthcare costs.